Quest Diagnostics (DGX) Price to FCF (2009 - 2026)

Quest Diagnostics has disclosed Price to FCF across 18 years of filings, most recently posting 50.97 for Q2 2026.

• In Q2 2026, Price to FCF rose 10.63% year-over-year to 50.97; the TTM figure through Jun 2026 stood at 17.34 (up 5.67% YoY), while the FY2025 annual figure was 14.03, down 23.83% from the prior year.
• Price to FCF came in at 50.97 for Q2 2026 at Quest Diagnostics, down from 132.28 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 295.75 in Q1 2024 to a low of 480.21 in Q1 2023.
• Average Price to FCF over 5 years is 47.7, with a median of 50.78 recorded in 2026.
• The largest YoY upside for Price to FCF was 269.15% in 2023 against a maximum downside of 1346.68% in 2023.
• Over 5 years, Price to FCF stood at 93.13 in 2022, then slumped by 63.98% to 33.55 in 2023, then surged by 46.35% to 49.1 in 2024, then advanced by 26.49% to 62.1 in 2025, then declined by 17.93% to 50.97 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 50.97 in Q2 2026, 132.28 in Q1 2026, and 62.1 in Q4 2025.